摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-methyl-6-(thiophen-2-yl)nicotinohydrazide

中文名称
——
中文别名
——
英文名称
2-methyl-6-(thiophen-2-yl)nicotinohydrazide
英文别名
2-Methyl-6-(2-thienyl)pyridine-3-carbohydrazide;2-methyl-6-thiophen-2-ylpyridine-3-carbohydrazide
2-methyl-6-(thiophen-2-yl)nicotinohydrazide化学式
CAS
——
化学式
C11H11N3OS
mdl
——
分子量
233.294
InChiKey
WOKRYHJCCGNCFN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    96.2
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-methyl-6-(thiophen-2-yl)nicotinohydrazide盐酸 、 sodium nitrite 作用下, 以 为溶剂, 反应 2.0h, 生成 2-methyl-6-(thiophen-2-yl)nicotinoyl azide
    参考文献:
    名称:
    某些新型1-(2-甲基-6-芳基吡啶-3-基)-3-苯基脲作为细胞凋亡诱导剂的合成及体外抗癌活性
    摘要:
    抽象的 结合我们关于新型抗癌候选药物开发的研究计划,在此我们报告新型1-(2-甲基-6-芳基吡啶3-3-基)-3-苯基脲5a-1的设计和合成。评价目标吡啶类化合物对两种癌细胞系的体外抗癌活性:非小细胞肺癌A549细胞系和结肠癌HCT-116细胞系。化合物5l是A549和HCT-116细胞系中活性最高的同源物,IC 50值分别等于3.22±0.2和2.71±0.16 µM,与阿霉素相当。分别为2.93±0.28和3.10±0.22。此外,化合物5l在US-NCI发展治疗计划抗癌试验中,脱氧核糖核酸是最有效的吡啶衍生物(平均GI = 40),对所有亚板中测试最多的癌细胞系均具有广谱抗肿瘤活性。化合物51能够在HCT-116细胞中引起凋亡,这由抗凋亡Bcl-2蛋白的表达降低和促凋亡蛋白水平的表达增强所证明。Bax,细胞色素C,p53,caspase-3和caspase-9。此外,5l通过改变Sub-G
    DOI:
    10.1080/14756366.2018.1547286
  • 作为产物:
    描述:
    参考文献:
    名称:
    某些新型取代烟碱的合成及其抗菌活性的评价
    摘要:
    合成了一些新颖的取代尼古丁,并通过分光镜进行了表征,其中烟酸酰肼(6a)和/或(6b)被用作by的合成中间体(8a-1)和(10a-f)的关键中间体。分别与不同的芳族醛(7a-f)和异丁烯(9a-e)反应。此外,烟酸酰肼与2,4-戊烷戊烷(11),2-乙氧基亚甲基丙二腈(13)和硫代半脲(15)反应生成吡唑(12),(14)和1,2,4-三唑(16) ), 分别。测试了新合成的化合物对9种微生物菌株的抵抗力。这些化合物中的一些显示出对几种微生物的显着活性。确定化合物(8d),(10b)和(10c)是最具活性的化合物。化合物(8d)显示出对金黄色葡萄球菌,枯草芽孢杆菌和A.的活性。与参考药物相比,IZ分别为IZ = 2.4、3.2和2.6 mm(Amoxicillin,IZ = 2.3、3.5和Griseofulvin,IZ = 2.4 mm)。此外,与参考药物(阿莫西林,IZ = 2.2毫米和灰黄霉素,IZ
    DOI:
    10.21608/ejchem.2019.13805.1853
点击查看最新优质反应信息

文献信息

  • Microscale Parallel Synthesis of Acylated Aminotriazoles Enabling the Development of Factor XIIa and Thrombin Inhibitors
    作者:Simon Platte、Marvin Korff、Lukas Imberg、Ilker Balicioglu、Catharina Erbacher、Jonas M. Will、Constantin G. Daniliuc、Uwe Karst、Dmitrii V. Kalinin
    DOI:10.1002/cmdc.202100431
    日期:2021.12.14
    approach toward N-acylated aminotriazoles is reported, enabling the compounds’ screening against FXIIa and thrombin. This approach afforded low-nanomolar FXIIa and thrombin inhibitors with no off-targeting of the other tested serine proteases. Selected compounds were shown to be covalent inhibitors of FXIIa and demonstrated anticoagulant properties in vitro, influencing the intrinsic blood coagulation
    抗凝剂进展:报道了一种 N-酰化氨基三唑的微量平行合成方法,使该化合物能够针对 FXIIa 和凝血酶进行筛选。这种方法提供了低纳摩尔浓度的 FXIIa 和凝血酶抑制剂,且其他测试的丝氨酸蛋白酶没有脱靶。选定的化合物被证明是 FXIIa 的共价抑制剂,并在体外表现出抗凝血特性,影响内在的凝血途径。
  • Design, Synthesis and Antitubercular Activity of Certain Nicotinic Acid Hydrazides
    作者:Wagdy Eldehna、Mohamed Fares、Marwa Abdel-Aziz、Hatem Abdel-Aziz
    DOI:10.3390/molecules20058800
    日期:——
    Three series of 6-aryl-2-methylnicotinohydrazides 4a–i, N′-arylidene-6-(4-bromophenyl)-2-methylnicotino hydrazides 7a–f, and N′-(un/substituted 2-oxoindolin-3-ylidene)-6-(4-fluorophenyl)-2-methylnicotinohydrazides 8a–c were synthesized and evaluated for their potential in vitro antimycobacterial activity against M. tuberculosis. The results showed that isatin hydrazides 8a–c are remarkably more active than the parent hydrazide 4c. Hydrazides 8b and 8c exhibited the highest activity among all the tested compounds (MIC = 12.5 and 6.25 µg/mL, respectively). Compounds 8b and 8c were also devoid of apparent cytotoxicity to HT-29, PC-3, A549, HepG2 and MCF-7 cancer cell lines. Besides, 8b and 8c showed good drug-likeness scores of 0.62 and 0.41, respectively. Those two isatin hydrazides could offer an excellent framework for future development to obtain more potent antitubercular agents. The SAR study suggested that lipophilicity of the synthesized derivatives is a crucial element that accounts for their antimycobacterial activity. Finally, a theoretical kinetic study was established to predict the ADME of the active derivatives.
    合成了三系列6-芳基-2-甲基烟碱酰肼4a–i、N'-芳亚甲基-6-(4-溴苯基)-2-甲基烟碱酰肼7a–f和N'-(未/取代的2-氧代吲哚啉-3-亚甲基)-6-(4-氟苯基)-2-甲基烟碱酰肼8a–c,并评估了它们对结核杆菌的体外抗菌活性。结果显示,靛红酰肼8a–c相较于母体酰肼4c活性显著更高。酰肼8b和8c在所有测试化合物中显示出最高的活性(MIC分别为12.5和6.25 µg/mL)。化合物8b和8c对HT-29、PC-3、A549、HepG2和MCF-7癌细胞系也无明显细胞毒性。此外,8b和8c显示出良好的类药性得分,分别为0.62和0.41。这两个靛红酰肼为未来开发更强效的抗结核药物提供了极佳的基础。SAR研究表明,合成衍生物的亲脂性是影响其抗结核活性的关键因素。最后,建立了理论动力学研究来预测活性衍生物的ADME。
  • Synthesis of Some Novel Substituted Nicotines and Evaluation of Their Antimicrobial Activity
    作者:Doaa Masoud、Rasha Azzam、Hussein Hussein、Aml Mekawey、Hatem Abdel-Aziz
    DOI:10.21608/ejchem.2019.13805.1853
    日期:2019.7.10
    nicotines were synthesized and characterized by spectroscopic means where nicotinic acid hydrazide (6a) and/or (6b) are used as a key intermediate in the synthesis of hydrazones (8a-l) and (10a-f) by the reaction with different aromatic aldehydes (7a-f) and isatines (9a-e), respectively. Moreover, nicotinic acid hydrazide reacted with pentane-2,4-dione (11), 2-ethoxymethylene-malononitrile (13) and thiosemicarbazone
    合成了一些新颖的取代尼古丁,并通过分光镜进行了表征,其中烟酸酰肼(6a)和/或(6b)被用作by的合成中间体(8a-1)和(10a-f)的关键中间体。分别与不同的芳族醛(7a-f)和异丁烯(9a-e)反应。此外,烟酸酰肼与2,4-戊烷戊烷(11),2-乙氧基亚甲基丙二腈(13)和硫代半脲(15)反应生成吡唑(12),(14)和1,2,4-三唑(16) ), 分别。测试了新合成的化合物对9种微生物菌株的抵抗力。这些化合物中的一些显示出对几种微生物的显着活性。确定化合物(8d),(10b)和(10c)是最具活性的化合物。化合物(8d)显示出对金黄色葡萄球菌,枯草芽孢杆菌和A.的活性。与参考药物相比,IZ分别为IZ = 2.4、3.2和2.6 mm(Amoxicillin,IZ = 2.3、3.5和Griseofulvin,IZ = 2.4 mm)。此外,与参考药物(阿莫西林,IZ = 2.2毫米和灰黄霉素,IZ
  • Synthesis and<i>in vitro</i>anticancer activity of certain novel 1-(2-methyl-6-arylpyridin-3-yl)-3-phenylureas as apoptosis-inducing agents
    作者:Wagdy M. Eldehna、Ghada S. Hassan、Sara T. Al-Rashood、Tarfah Al-Warhi、Ahmed E. Altyar、Hamad M. Alkahtani、Abdulrahman A. Almehizia、Hatem A. Abdel-Aziz
    DOI:10.1080/14756366.2018.1547286
    日期:2019.1.1
    Abstract In connection with our research program on the development of novel anticancer candidates, herein we report the design and synthesis of novel series of 1-(2-methyl-6-arylpyridin-3-yl)-3-phenylureas 5a–l. The target pyridins were evaluated for their in vitro anticancer activity against two cancer cell lines: non-small cell lung cancer A549 cell line and colon cancer HCT-116 cell line. Compound
    抽象的 结合我们关于新型抗癌候选药物开发的研究计划,在此我们报告新型1-(2-甲基-6-芳基吡啶3-3-基)-3-苯基脲5a-1的设计和合成。评价目标吡啶类化合物对两种癌细胞系的体外抗癌活性:非小细胞肺癌A549细胞系和结肠癌HCT-116细胞系。化合物5l是A549和HCT-116细胞系中活性最高的同源物,IC 50值分别等于3.22±0.2和2.71±0.16 µM,与阿霉素相当。分别为2.93±0.28和3.10±0.22。此外,化合物5l在US-NCI发展治疗计划抗癌试验中,脱氧核糖核酸是最有效的吡啶衍生物(平均GI = 40),对所有亚板中测试最多的癌细胞系均具有广谱抗肿瘤活性。化合物51能够在HCT-116细胞中引起凋亡,这由抗凋亡Bcl-2蛋白的表达降低和促凋亡蛋白水平的表达增强所证明。Bax,细胞色素C,p53,caspase-3和caspase-9。此外,5l通过改变Sub-G
  • Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agents
    作者:Wagdy M. Eldehna、Ayman Altoukhy、Hoda Mahrous、Hatem A. Abdel-Aziz
    DOI:10.1016/j.ejmech.2014.12.010
    日期:2015.1
    A hybrid pharmacophore approach was adopted to design and synthesize new series of isatin-pyridine hybrids. All the newly prepared hybrids (5a-o, 8 and 11a-d) were in vitro evaluated for their antiproliferative activity against three human cancer cell lines, namely HepG2 hepatocellular carcinoma, A549 lung cancer and MCF-7 breast cancer. Compound 8 emerged as the most active member against HepG2 cell line (IC50 = 2.5 +/- 0.39 mu M), with 2.7-fold increased activity than the reference drug, doxorubicin (IC50 = 6.9 +/- 2.05 mu M). Whilst, compound 11c was found to be the most potent counterpart against A549 and MCF-7 cell lines with IC50 values of 10.8 +/- 1.15 and 6.3 +/- 0.79, respectively. The weightiness of the utilization of non-cleavable linker, as the chalcone linker, and simplification of the first group, was explored via the SAR study. Furthermore, a QSAR model was built to explore the structural requirements controlling the cytotoxic activities. Notably, the predicted activities by the QSAR model were very close to those experimentally observed, hinting that this model could be safely applied for prediction of more efficacious hits comprising the same skeletal framework. Finally, a theoretical kinetic study was established to predict the ADME of the active hybrids. (C) 2014 Elsevier Masson SAS. All rights reserved.
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-